Acumen Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $216.1M | $108.8M |
| Jun 2022 | — | $206.5M | $111.1M |
| Sep 2022 | — | $196.7M | $157.5M |
| Dec 2022 | $0 | $188.8M | $130.1M |
| Mar 2023 | — | $179.1M | $78.0M |
| Jun 2023 | — | $168.9M | $77.2M |
| Sep 2023 | — | $280.3M | $94.9M |
| Dec 2023 | $29.9M | $267.0M | $66.9M |
| Mar 2024 | $30.2M | $262.0M | $46.9M |
| Jun 2024 | $29.4M | $243.9M | $68.0M |
| Sep 2024 | $29.7M | $217.2M | $33.2M |
| Dec 2024 | $29.4M | $181.8M | $35.6M |
| Mar 2025 | $29.5M | $155.5M | $30.2M |
| Jun 2025 | $29.9M | $117.1M | $36.8M |
| Sep 2025 | $27.1M | $93.2M | $46.8M |
| Dec 2025 | $22.4M | $70.4M | $54.0M |
| Mar 2026 | $16.9M | $87.5M | $51.8M |
| Jun 2026 | $11.9M | $57.3M | $59.4M |